- Home
- BEEM vs PYPD Comparison
BEEM vs PYPD Comparison
Compare BEEM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- PYPD
- Stock Information
- Founded
- BEEM 2006
- PYPD 2008
- Country
- BEEM United States
- PYPD Israel
- Employees
- BEEM N/A
- PYPD N/A
- Industry
- BEEM Semiconductors
- PYPD Medical/Dental Instruments
- Sector
- BEEM Technology
- PYPD Health Care
- Exchange
- BEEM Nasdaq
- PYPD Nasdaq
- Market Cap
- BEEM 22.3M
- PYPD 25.0M
- IPO Year
- BEEM N/A
- PYPD 2020
- Fundamental
- Price
- BEEM $1.39
- PYPD $2.75
- Analyst Decision
- BEEM Strong Buy
- PYPD Strong Buy
- Analyst Count
- BEEM 4
- PYPD 2
- Target Price
- BEEM $9.00
- PYPD $10.50
- AVG Volume (30 Days)
- BEEM 193.6K
- PYPD 10.5K
- Earning Date
- BEEM 04-11-2025
- PYPD 05-07-2025
- Dividend Yield
- BEEM N/A
- PYPD N/A
- EPS Growth
- BEEM N/A
- PYPD N/A
- EPS
- BEEM N/A
- PYPD N/A
- Revenue
- BEEM $49,336,000.00
- PYPD N/A
- Revenue This Year
- BEEM $27.41
- PYPD N/A
- Revenue Next Year
- BEEM $58.00
- PYPD N/A
- P/E Ratio
- BEEM N/A
- PYPD N/A
- Revenue Growth
- BEEM N/A
- PYPD N/A
- 52 Week Low
- BEEM $1.33
- PYPD $2.30
- 52 Week High
- BEEM $7.68
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- BEEM 30.42
- PYPD 52.19
- Support Level
- BEEM $1.33
- PYPD $2.65
- Resistance Level
- BEEM $1.48
- PYPD $2.76
- Average True Range (ATR)
- BEEM 0.19
- PYPD 0.11
- MACD
- BEEM -0.02
- PYPD 0.03
- Stochastic Oscillator
- BEEM 7.50
- PYPD 93.75
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.